IP Library Granted Patent US 8,648,091
Granted Patent B2
US 8,648,091 · App. 12/740,869 · Granted Feb 11, 2014

Dihydroquinolinones as ectoparasiticides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,648,091
App. No.
12/740,869
Granted
Feb 11, 2014
Kind
B2
Abstract

Disclosed are uses of dihydroquinolinone derivatives for combating ectoparasites on non-human animals. Example ectoparasites include, for example, representatives of the order acarina, including ticks and mites. Also disclosed are compositions containing dihydroquinolinone derivatives.

Claims (4)

1. A method of controlling ticks on a non-human animal, comprising applying topically and/or locally to the animal a tickicidally effective amount of the compound of the formula

or a stereoisomer thereof, which compound is in free form or salt form.

2. The method of claim 1 wherein the tickicidally effective amount of Compound No. 11 is 25 mg/kg.

3. The method of claim 1 wherein a pour-on or spot-on formulation is applied topically and/or locally to the animal.

Assignments (3)
CHANGE OF NAME Recorded Aug 25, 2017
From: NOVARTIS TIERGESUNDHEIT AG
To: ELANCO TIERGESUNDHEIT AG
Reel/Frame 043402/0680 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2015
From: NOVARTIS AG
To: NOVARTIS TIERGESUNDHEIT AG
Reel/Frame 034926/0844 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2010
From: KEMPTER, CHRISTOPH; ROOS, ULRICH; SCHORDERET WEBER, SANDRA; EBINGER, YVONNE; GLASER, SILVIA
To: NOVARTIS AG
Reel/Frame 024318/0194 →